These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34516583)
21. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W Front Immunol; 2018; 9():597. PubMed ID: 29740424 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Zika virus neutralizing antibodies in normal healthy Thais. Sornjai W; Jaratsittisin J; Auewarakul P; Wikan N; Smith DR Sci Rep; 2018 Nov; 8(1):17193. PubMed ID: 30464242 [TBL] [Abstract][Full Text] [Related]
23. DETECTION OF HUMAN ANTI-ZIKA VIRUS IgG BY ELISA USING AN ANTIGEN FROM in vitro INFECTED VERO CELLS: PRELIMINARY RESULTS. Sumita LM; Rodrigues JP; Ferreira NE; Felix AC; Souza NC; Machado CM; Júnior HF Rev Inst Med Trop Sao Paulo; 2016 Dec; 58():89. PubMed ID: 27982355 [TBL] [Abstract][Full Text] [Related]
24. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies. Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550 [TBL] [Abstract][Full Text] [Related]
25. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor. Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557 [TBL] [Abstract][Full Text] [Related]
26. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections. Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827 [TBL] [Abstract][Full Text] [Related]
28. Zika Virus Antibody Titers Three Years after Confirmed Infection. Langerak T; Kasbergen LMR; Chandler F; Brinkman T; Faerber Z; Phalai K; Ulbert S; Rockstroh A; Bruin E; Koopmans MPG; Rockx B; van Gorp ECM; Vreden S Viruses; 2021 Jul; 13(7):. PubMed ID: 34372551 [TBL] [Abstract][Full Text] [Related]
29. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia. Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135 [TBL] [Abstract][Full Text] [Related]
34. Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans. Malafa S; Medits I; Aberle JH; Aberle SW; Haslwanter D; Tsouchnikas G; Wölfel S; Huber KL; Percivalle E; Cherpillod P; Thaler M; Roßbacher L; Kundi M; Heinz FX; Stiasny K PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008034. PubMed ID: 32017766 [TBL] [Abstract][Full Text] [Related]
35. Family Planning and Zika Virus: The Power of Prevention. Burke A; Moreau C Semin Reprod Med; 2016 Sep; 34(5):305-312. PubMed ID: 27612157 [TBL] [Abstract][Full Text] [Related]
36. Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus). Azami NAM; Moi ML; Ami Y; Suzaki Y; Lim CK; Taniguchi S; Saijo M; Takasaki T; Kurane I Virol J; 2018 Mar; 15(1):51. PubMed ID: 29587780 [TBL] [Abstract][Full Text] [Related]
37. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016-2017. Chepkorir E; Tchouassi DP; Konongoi SL; Lutomiah J; Tigoi C; Irura Z; Eyase F; Venter M; Sang R Virol J; 2019 May; 16(1):65. PubMed ID: 31101058 [TBL] [Abstract][Full Text] [Related]